Elevance, formerly known as Anthem, Inc., has an exclusion in some of its health insurance plans that denies coverage of “‘any drug mainly used for weight loss,’” such as Ozempic and Wegovy. The denial of coverage “targets disabled enrollees who seek medically necessary weight loss treatment for their disability of obesity,” the complaint, filed in the US District Court for the District of Maine, ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.